U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Nonprogressive cerebellar ataxia

MedGen UID:
335079
Concept ID:
C1845029
Finding
Synonym: Cerebellar ataxia, nonprogressive
 
HPO: HP:0002470

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVNonprogressive cerebellar ataxia

Conditions with this feature

X-linked sideroblastic anemia with ataxia
MedGen UID:
335078
Concept ID:
C1845028
Disease or Syndrome
X-linked spinocerebellar ataxia-6 with or without sideroblastic anemia (SCAX6) is an X-linked recessive disorder characterized by delayed motor development apparent in infancy with delayed walking (often by several years) due to ataxia and poor coordination. Additional features may include dysmetria, dysarthria, spasticity of the lower limbs, hyperreflexia, dysdiadochokinesis, strabismus, and nystagmus. The disorder is slowly progressive, and patients often lose ambulation. Brain imaging usually shows cerebellar atrophy. Most affected individuals have mild hypochromic, microcytic sideroblastic anemia, which may be asymptomatic. Laboratory studies show increased free erythrocyte protoporphyrin (FEP) and ringed sideroblasts on bone marrow biopsy. Female carriers do not have neurologic abnormalities, but may have subtle findings on peripheral blood smear (Pagon et al., 1985; D'Hooghe et al., 2012). For a discussion of genetic heterogeneity of X-linked spinocerebellar ataxia (SCAX), see SCAX1 (302500).
3-methylglutaconic aciduria type 5
MedGen UID:
347542
Concept ID:
C1857776
Disease or Syndrome
3-Methylglutaconic aciduria type V (MGCA5) is an autosomal recessive disorder characterized by the onset of dilated or noncompaction cardiomyopathy in infancy or early childhood. Many patients die of cardiac failure. Other features include microcytic anemia, growth retardation, mild ataxia, mild muscle weakness, genital anomalies in males, and increased urinary excretion of 3-methylglutaconic acid. Some patients may have optic atrophy or delayed psychomotor development (summary by Davey et al., 2006 and Ojala et al., 2012). For a discussion of genetic heterogeneity of 3-methylglutaconic aciduria, see MGCA type I (250950).
Spinocerebellar ataxia type 29
MedGen UID:
350085
Concept ID:
C1861732
Disease or Syndrome
Spinocerebellar ataxia-29 (SCA29) is an autosomal dominant neurologic disorder characterized by onset in infancy of delayed motor development and mild cognitive delay. Affected individuals develop a very slowly progressive or nonprogressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor (summary by Huang et al., 2012). For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).

Professional guidelines

PubMed

Expert Panel on Pediatric Imaging, Radhakrishnan R, Shea LAG, Pruthi S, Silvera VM, Bosemani T, Desai NK, Gilbert DL, Glenn OA, Guimaraes CV, Ho ML, Lam HFS, Maheshwari M, Mirsky DM, Nadel HR, Partap S, Schooler GR, Udayasankar UK, Whitehead MT, Wright JN, Rigsby CK
J Am Coll Radiol 2022 Nov;19(11S):S240-S255. doi: 10.1016/j.jacr.2022.09.010. PMID: 36436955
Nuovo S, Baglioni V, De Mori R, Tardivo S, Caputi C, Ginevrino M, Micalizzi A, Masuelli L, Federici G, Casella A, Lorefice E, Anello D, Tolve M, Farini D, Bertini E, Zanni G, Travaglini L, Vasco G, Sette C, Carducci C, Valente EM, Leuzzi V
Hum Mutat 2022 Jan;43(1):67-73. Epub 2021 Nov 15 doi: 10.1002/humu.24293. PMID: 34747546

Recent clinical studies

Prognosis

Qi Y, Ji X, Ding H, Liu L, Zhang Y, Yin A
Front Genet 2022;13:821587. Epub 2022 Mar 10 doi: 10.3389/fgene.2022.821587. PMID: 35360849Free PMC Article
Bertini E, Zanni G, Boltshauser E
Handb Clin Neurol 2018;155:91-103. doi: 10.1016/B978-0-444-64189-2.00006-8. PMID: 29891079
Oatts JT, Duncan JL, Hoyt CS, Slavotinek AM, Moore AT
Ophthalmic Genet 2017 Dec;38(6):559-561. Epub 2017 Mar 2 doi: 10.1080/13816810.2017.1290118. PMID: 28635423
Ali BR, Silhavy JL, Gleeson MJ, Gleeson JG, Al-Gazali L
BMC Med Genet 2012 Sep 14;13:80. doi: 10.1186/1471-2350-13-80. PMID: 22973972Free PMC Article
Tsao JW, Neal J, Apse K, Stephan MJ, Dobyns WB, Hill RS, Walsh CA, Sheen VL
Arch Neurol 2006 Apr;63(4):594-7. doi: 10.1001/archneur.63.4.594. PMID: 16606775

Clinical prediction guides

Oatts JT, Duncan JL, Hoyt CS, Slavotinek AM, Moore AT
Ophthalmic Genet 2017 Dec;38(6):559-561. Epub 2017 Mar 2 doi: 10.1080/13816810.2017.1290118. PMID: 28635423
Ali BR, Silhavy JL, Gleeson MJ, Gleeson JG, Al-Gazali L
BMC Med Genet 2012 Sep 14;13:80. doi: 10.1186/1471-2350-13-80. PMID: 22973972Free PMC Article
Tsao JW, Neal J, Apse K, Stephan MJ, Dobyns WB, Hill RS, Walsh CA, Sheen VL
Arch Neurol 2006 Apr;63(4):594-7. doi: 10.1001/archneur.63.4.594. PMID: 16606775
Dudding TE, Friend K, Schofield PW, Lee S, Wilkinson IA, Richards RI
Neurology 2004 Dec 28;63(12):2288-92. doi: 10.1212/01.wnl.0000147299.80872.d1. PMID: 15623688
Steinlin M, Styger M, Boltshauser E
Neurology 1999 Sep 22;53(5):966-73. doi: 10.1212/wnl.53.5.966. PMID: 10496254

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...